Multiple Sclerosis

The NeurologyLive® MS Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with multiple sclerosis and demyelinating disorders.

Latest News

Matthew R. Brier, MD, PhD, neurology chief resident at Washington University in St. Louis
Increased Aerobic Glycolysis in Normal Appearing White Matter Revealed as Metabolic Abnormality in Multiple Sclerosis

March 3rd 2024

A recent study presented at the 2024 ACTRIMS Forum suggests that increased aerobic glycolysis in normal appearing white matter may be an early feature of multiple sclerosis.

Joanna Kocot, PhD, Rocky Beth fellow at National Institutes of Health
Clemastine Arm of TRAP-MS Trial Halted Following Increased Disability Accumulation in Progressive Multiple Sclerosis

March 2nd 2024

Fumie Hayashi, MD, PhD, a postdoctoral fellow in the department of Neurology at University of California, San Francisco
Study Reveals Expanded CD8+ T Cell Clonotypes in Cerebrospinal Fluid in Patients With Multiple Sclerosis

March 2nd 2024

Theodore H. Schwartz, MD, professor of neurological surgery at Weill Cornell Medicine
Paramagnetic Rim Lesions Predicts Future Cognitive Decline in Multiple Sclerosis

March 2nd 2024

Yinan Zhang, MD, assistant professor of neurology at The Ohio State University Wexner Medical Center
Epigenetic Age Acceleration Shows Association With Secondary Progressive Multiple Sclerosis

March 2nd 2024

© 2024 MJH Life Sciences

All rights reserved.